a clear trendp = 0.03
Nevertheless, we see a clear trend where, of the CST types, CST I-A at baseline was most strongly associated with NILM at six-months (26/32, 81.2%, OR 0.32, 95% CI 0.12–0.82, p = 0.03, q = 0.15, Fisher’s exact test), while CST IV-A at baseline was most strongly associated with SIL outcomes at six-months (9/15, 60%, OR 3.07, 95% CI 1.03–9.40, p = 0.04, q = 0.16), however, the associations were only moderate when corrected for multiple testing (FDR < 0.2) (Fig. 2 a-b).